What the company does
GNI Group Ltd., together with its subsidiaries, engages in the research, development, manufacturing, and sale of pharmaceuticals and biomaterials in Japan, China, and the United States. It operates in two segments, Pharmaceutical Business and Medical Equipment Business. The company offers ETUARY for the treatment of idiopathic pulmonary fibrosis; H-GENIN Crush-Mix for the treatment of bone defects; AltiPly for the treatment of acute and chronic wounds; and orthobiologics products. It also develops ETUARY which is in Phase III clinical trial for the treatment of pneumoconiosis, dermatomyositis interstitial lung disease, and systemic sclerosis-associated interstitial lung disease; and …
What the weekly tape is saying
2160 closed the latest completed week at 2,520 JPY. The 4-week return is -14.7% and the 12-week return is -11.3%. Trend Signal is inactive, Market Dynamics is -0.73. Setup signature: Risk-first tape with a 16/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 2,789 JPY
- Vs Trend Line
- -9.6%
- Fair Value
- 2,640 JPY
- Vs Fair Value
- -4.5%
- 52W High
- 3,950 JPY
- 52W Low
- 2,112 JPY
- Drawdown
- -36.2%
- Range Position
- 22.2%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 16
- 52W Active Breadth
- 30.8%
- Sector Scope
- JP Healthcare
- Sector Rank
- 209 of 223
- Sector Percentile
- 6.3%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
JP Healthcare
- Tracked Peers
- 100
- 4W Rank
- 89 of 100
- Avg 1W
- -1.3%
- Avg 4W
- -3.4%
- Trend Breadth
- 27.0%
- Positive MD
- 28.0%
JP Biotechnology
- Tracked Peers
- 48
- 4W Rank
- 20 of 48
- Avg 1W
- -6.1%
- Avg 4W
- -16.7%
- Trend Breadth
- 12.5%
- Positive RS
- 2.1%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.73
- 4W MD Change
- -2817.8%
- Relative Strength
- -31.41
- 4W RS Change
- -56.9%
- Expectation
- Undecided
- Probability
- 52.16%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 10.3M
- 13W Average
- 5.7M
- 52W Average
- 6.2M
- Vs 13W
- 1.8x
- Vs 52W
- 1.7x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 7.6%
- 52W Volatility
- 6.8%
- Upside Weeks
- 23
- Downside Weeks
- 29
- Downside Breadth
- 55.8%
- Avg Gain / Loss
- 5.5% / -5.3%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- JPX
- Country
- JP
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- JPY
- Market Cap
- 141.9B
Opportunity signals
- Volume is elevated versus the 13-week average, confirming attention.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 2,520 JPY | -11.0% | 2,789 JPY | 2,640 JPY | -0.73 | -31.41 | 10.3M | Off |
| 5 Jun 2026 | 2,833 JPY | 11.3% | 2,788 JPY | 2,633 JPY | -0.58 | -25.07 | 5.8M | Off |
| 29 May 2026 | 2,546 JPY | -10.2% | 2,778 JPY | 2,622 JPY | -0.44 | -33.88 | 5.7M | On |
| 22 May 2026 | 2,834 JPY | -4.1% | 2,774 JPY | 2,612 JPY | -0.19 | -24.79 | 7.4M | On |
| 15 May 2026 | 2,955 JPY | -0.8% | 2,762 JPY | 2,601 JPY | 0.03 | -20.02 | 5.8M | On |
| 8 May 2026 | 2,979 JPY | -1.4% | 2,742 JPY | 2,589 JPY | 0.29 | -21.64 | 1.5M | On |
| 1 May 2026 | 3,020 JPY | -3.5% | 2,720 JPY | 2,577 JPY | 0.53 | -16.70 | 3.5M | On |
| 24 Apr 2026 | 3,130 JPY | -7.1% | 2,700 JPY | 2,564 JPY | 0.75 | -14.36 | 5.0M | On |
| 17 Apr 2026 | 3,370 JPY | 6.0% | 2,674 JPY | 2,550 JPY | 1.00 | -6.18 | 4.0M | On |
| 10 Apr 2026 | 3,180 JPY | 1.1% | 2,648 JPY | 2,536 JPY | 0.95 | -9.24 | 4.0M | On |
| 3 Apr 2026 | 3,145 JPY | -3.2% | 2,628 JPY | 2,522 JPY | 1.17 | -3.75 | 5.5M | On |
| 27 Mar 2026 | 3,250 JPY | 14.4% | 2,612 JPY | 2,509 JPY | 1.44 | -0.76 | 9.0M | On |
| 20 Mar 2026 | 2,842 JPY | -9.6% | 2,594 JPY | 2,495 JPY | 1.42 | -13.18 | 6.2M | On |
| 13 Mar 2026 | 3,145 JPY | -12.4% | 2,588 JPY | 2,483 JPY | 1.69 | -4.98 | 9.4M | On |